Impact of a drug allergy education course for non‐specialists: Findings from ADAPT— A randomized crossover trial
Allergy · 2025
DOI: 10.1111/all.16270 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Allergy, 2025. Verfasst von Michaela Lucas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Drug Hypersensitivity. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The consequences of drug allergy remain a global health concern. Drug allergy is often a neglected topic and many non‐specialists lack sufficient knowledge or confidence in evaluating or managing this common condition. Evidence‐based interventions to better equip non‐specialists to tackle drug allergy are needed. The aim of the study is to evaluate the effectiveness of an intensive educational course on drug allergy knowledge and practice of non‐specialists.
Methods
A randomized crossover trial (NCT06399601) was conducted among practicing physicians and nurses participating in an intensive drug allergy course—Advances in Drug Allergy & Penicillin Testing (ADAPT). Participants' baseline knowledge and self‐reported practices were assessed with standardized questionnaires (scored from 0 to 100, with “satisfactory” defined as ≥60/100). Participants were randomized into two cohorts and attended ADAPT at different time points. Serial responses before and after the course were compared within and between cohorts.
Results
Seventy participants (25 physicians, 45 nurses) randomized into two groups completed the course. Baseline drug allergy knowledge (58.0 ± 19.9) and self‐reported practice (36.9 ± 24.3) were unsatisfactory among non‐specialists, with significantly lower scores from nurses than physicians in both domains (knowledge: 49.0 ± 17.4 vs. 74.0 ± 12.7; practice: 32.1 ± 21.3 vs. 53.3 ± 23.1; all p < 0.001). Following completion of ADAPT, participants demonstrated significant improvements in knowledge (58.0 ± 19.9 vs. 77.7 ± 15.9, p < 0.001) and self‐reported practice (36.9 ± 24.3 vs. 71.0 ± 20.2, p < 0.001). All participants (100%) and 99% of participants agreed that the course improved their clinical knowledge and practice, respectively.
Conclusions
ADAPT, an intensive drug allergy educational course was effective in improving drug allergy knowledge and practice for non‐specialists. Further longitudinal studies are required to evaluate long‐term impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Immunology Department, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Medical School, University of Western Australia, Perth, Western Australia, Australia.
- Immunology Department, Perth Children's Hospital, Perth, Western Australia, Australia.
- Immunology Department, PathWest Laboratory Medicine, Perth, Western Australia, Australia.
- Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.
- School of Nursing, The University of Hong Kong, Pokfulam, Hong Kong.
ORCID-Profile: Philip H Li
Zitieren
APA
Lucas, M., Mak, H. W. F., Lee, J. T. Y., Kulkarni, R., Chan, S. S. C., & Li, P. H. (2025). Impact of a drug allergy education course for non‐specialists: Findings from ADAPT— A randomized crossover trial. Allergy. https://doi.org/10.1111/all.16270
Vancouver
Lucas M, Mak HWF, Lee JTY, Kulkarni R, Chan SSC, Li PH. Impact of a drug allergy education course for non‐specialists: Findings from ADAPT— A randomized crossover trial. Allergy. 2025. doi:10.1111/all.16270
BibTeX
@article{Lucas2025,
author = {Lucas, Michaela and Mak, Hugo W F and Lee, Jasmine T Y and Kulkarni, Rishabh and Chan, Sophia S C and Li, Philip H},
title = {Impact of a drug allergy education course for non‐specialists: Findings from ADAPT— A randomized crossover trial},
journal = {Allergy},
year = {2025},
doi = {10.1111/all.16270}
}
EUVIMED